DaVita, a leading provider of dialysis services, has seen its stock price climb 47.3% this year, fueled by strategic acquisitions, strong second-quarter performance, and a focus on patient-centric care. The company is expanding its global reach, acquiring dialysis centers, and raising its earnings forecast for 2024, signaling a positive outlook.